Differential processing of pro-glucose-dependent insulinotropic polypeptide in gut

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 298, Issue 5, 2010, Pages

  Fujita, Yukihiro ^a,b   Asadi, Ali ^a   Yang, Gary K ^a   Kwok, Yin Nam ^a   Kieffer, Timothy J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

GIP; Incretin; PCSK; Perfused stomach

Indexed keywords

ANTIBODY; FURIN; GASTRIC INHIBITORY POLYPEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE[1-30]; GASTRIC INHIBITORY POLYPEPTIDE[1-42]; KEXIN; PROPROTEIN CONVERTASE 1; SOMATOSTATIN; SUBTILISIN; UNCLASSIFIED DRUG;

AMIDATION; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SUBPOPULATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE; MOUSE; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; SOMATOSTATIN RELEASE;

ANIMALS; ENTEROENDOCRINE CELLS; FURIN; GASTRIC INHIBITORY POLYPEPTIDE; HUMANS; MICE; PEPTIDE FRAGMENTS; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE 2; SOMATOSTATIN; STOMACH;

EID: 77951463380     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00024.2010     Document Type: Article

References (43)

1. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 132: 2131-2157, 2007.
2. Buchan AM, Ingman-Baker J, Levy J, Brown JC. A comparison of the ability of serum and monoclonal antibodies to gastric inhibitory polypeptide to detect immunoreactive cells in the gastroenteropancreatic system of mammals and reptiles. Histochemistry 76: 341-349, 1982.
3. Cataland S, Crockett SE, Brown JC, Mazzaferri EL. Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man. J Clin Endocrinol Metab 39: 223-228, 1974.
4. Chiba T, Park J, Yamada T. Biosynthesis of somatostatin in canine fundic D cells. J Clin Invest 81: 282-287, 1988. (Pubitemid 18075218)
5. Dupre J, Ross SA, Watson D, Brown JC. Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol Metab 37: 826-828, 1973.
6. Eckel RH, Fujimoto WY, Brunzell JD. Gastric inhibitory polypeptide enhanced lipoprotein lipase activity in cultured preadipocytes. Diabetes 28: 1141-1142, 1979. (Pubitemid 10215022)
7. Ehses JA, Casilla VR, Doty T, Pospisilik JA, Winter KD, Demuth HU, Pederson RA, McIntosh CH. Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase. Endocrinology 144: 4433-4445, 2003. (Pubitemid 37204843)
8. Eipper BA, Mains RE. Peptide alpha-amidation. Annu Rev Physiol 50: 333-344, 1988.
9. 1-42 as stimulators of proinsulin gene transcription. Peptides 16: 1149-1152, 1995.
10. Fujita Y, Wideman RD, Asadi A, Yang GK, Baker R, Webber T, Zhang T, Wang R, Ao Z, Warnock GL, Kwok FN, Kieffer TJ. Glucose-dependent insulinotropic polypeptide (GIP) is expressed in pancreatic islet alpha-cells and promotes insulin secretion. Gastroenterology. In Press.
11. Gagnon J, Mayne J, Mbikay M, Woulfe J, Chretien M. Expression of PCSK1 (PC1/3), PCSK2 (PC2) and PCSK3 (furin) in mouse small intestine. Regul Pept 152: 54-60, 2009.
12. Gallwitz B, Witt M, Folsch UR, Creutzfeldt W, Schmidt WE. Binding specificity and signal transduction of receptors for glucagon-like peptide-1 (7-36) amide and gastric inhibitory polypeptide on RINm5F insulinoma cells. J Mol Endocrinol 10: 259-268, 1993. (Pubitemid 23214912)
13. Irwin DM, Zhang T. Evolution of the vertebrate glucose-dependent insulinotropic polypeptide (GIP) gene. Comp Biochem Physiol D Genomics Proteomics 1: 385-395, 2006. (Pubitemid 44804305)
14. Irwin N, Flatt PR. Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications. Diabetologia 52: 1724-1731, 2009.
15. Jia X, Brown JC, Kwok YN, Pederson RA, McIntosh CH. Gastric inhibitory polypeptide and glucagon-like peptide-1(7-36) amide exert similar effects on somatostatin secretion but opposite effects on gastrin secretion from the rat stomach. Can J Physiol Pharmacol 72: 1215-1219, 1994.
16. Jornvall H, Carlquist M, Kwauk S, Otte SC, McIntosh CH, Brown JC, Mutt V. Amino acid sequence and heterogeneity of gastric inhibitory polypeptide (GIP). FEBS Lett 123: 205-210, 1981. (Pubitemid 11148752)
17. Kieffer TJ, McIntosh CH, Pederson RA. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136: 3585-3596, 1995.
18. Kieffer TJ, Verchere CB, Fell CD, Huang Z, Brown JC, Pedersen RA. Glucose-dependent insulinotropic polypeptide stimulated insulin release from a tumor-derived beta-cell line (beta TC3). Can J Physiol Pharmacol 71: 917-922, 1993. (Pubitemid 24097059)
19. Kim SJ, Nian C, McIntosh CH. Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade. J Biol Chem 282: 8557-8567, 2007. (Pubitemid 47093503)
20. Kim SJ, Winter K, Nian C, Tsuneoka M, Koda Y, McIntosh CH. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression. J Biol Chem 280: 22297-22307, 2005.
21. Knapper JM, Puddicombe SM, Morgan LM, Fletcher JM. Investigations into the actions of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1(7-36) amide on lipoprotein lipase activity in explants of rat adipose tissue. J Nutr 125: 183-188, 1995.
22. Maletti M, Altman JJ, Hoa DH, Carlquist M, Rosselin G. Evidence of functional gastric inhibitory polypeptide (GIP) receptors in human insulinoma. Binding of synthetic human GIP 1-31 and activation of adenylate cyclase. Diabetes 36: 1336-1340, 1987.
23. Marino L, Muglia B, Dickinson CJ. Glycine-extended post-translational processing intermediates of gastrin and cholecystokinin in the gut. Regul Pept 50: 73-85, 1994.
24. McIntosh CH. Gastrointestinal somatostatin: distribution, secretion and physiological significance. Life Sci 37: 2043-2058, 1985.
25. McIntosh CH, Kwok YN, Tang C, Brown JC. The use of monoclonal antibodies in radioimmunoassays for gastrointestinal hormones. J Clin Immunoassay 10: 679-684, 1987.
26. McIntosh CH, Pederson RA, Koop H, Brown JC. Gastric inhibitory polypeptide stimulated secretion of somatostatinlike immunoreactivity from the stomach: inhibition by acetylcholine or vagal stimulation. Can J Physiol Pharmacol 59: 468-472, 1981.
27. Meier JJ, Nauck MA, Schmidt WE, Gallwitz B. Gastric inhibitory polypeptide: the neglected incretin revisited. Regul Pept 107: 1-13, 2002.
28. Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, Hiai H, Mizunoya W, Fushiki T, Holst JJ, Makino M, Tashita A, Kobara Y, Tsubamoto Y, Jinnouchi T, Jomori T, Seino Y. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8: 738-742, 2002.
29. Miyawaki K, Yamada Y, Yano H, Niwa H, Ban N, Ihara Y, Kubota A, Fujimoto S, Kajikawa M, Kuroe A, Tsuda K, Hashimoto H, Yamashita T, Jomori T, Tashiro F, Miyazaki J, Seino Y. Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci USA 96: 14843-14847, 1999.
30. Morgan LM, Goulder TJ, Tsiolakis D, Marks V, Alberti KG. The effect of unabsorbable carbohydrate on gut hormones. Modification of post-prandial GIP secretion by guar. Diabetologia 17: 85-89, 1979.
31. Morrow GW, Kieffer TJ, McIntosh CH, MacGillivray RT, Brown JC, St Pierre S, Pederson RA. The insulinotropic region of gastric inhibitory polypeptide; fragment analysis suggests the bioactive site lies between residues 19 and 30. Can J Physiol Pharmacol 74: 65-72, 1996.
32. Musson MC, Jepeal LI, Mabray PD, Zhdanova IV, Cardoso WV, Wolfe MM. Expression of glucose-dependent insulinotropic polypeptide in the zebrafish. Am J Physiol Regul Integr Comp Physiol 297: R1803-R1812, 2009.
33. Oben J, Morgan L, Fletcher J, Marks V. Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1 (7-36) amide, on fatty acid synthesis in explants of rat adipose tissue. J Endocrinol 130: 267-272, 1991.
34. Paulsson JF, Westermark GT. Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation. Diabetes 54: 2117-2125, 2005.
35. Pederson RA, Brown JC. Inhibition of histamine-, pentagastrin-, and insulin-stimulated canine gastric secretion by pure "gastric inhibitory polypeptide." Gastroenterology 62: 393-400, 1972.
36. Rossowski WJ, Zacharia S, Mungan Z, Ozmen V, Ertan A, Baylor LM, Jiang NY, Coy DH. Reduced gastric acid inhibitory effect of a pGIP(1-30)NH2 fragment with potent pancreatic amylase inhibitory activity. Regul Pept 39: 9-17, 1992.
37. Trumper A, Trumper K, Horsch D. Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells. J Endocrinol 174: 233-246, 2002.
38. Trumper A, Trumper K, Trusheim H, Arnold R, Goke B, Horsch D. Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling. Mol Endocrinol 15: 1559-1570, 2001.
39. Ugleholdt R, Poulsen ML, Holst PJ, Irminger JC, Orskov C, Pedersen J, Rosenkilde MM, Zhu X, Steiner DF, Holst JJ. Prohormone convertase 1/3 is essential for processing of the glucose-dependent insulinotropic polypeptide precursor. J Biol Chem 281: 11050-11057, 2006.
40. Wang Y, Montrose-Rafizadeh C, Adams L, Raygada M, Nadiv O, Egan JM. GIP regulates glucose transporters, hexokinases, and glucose-induced insulin secretion in RIN 1046-38 cells. Mol Cell Endocrinol 116: 81-87, 1996.
41. Widenmaier SB, Kim SJ, Yang GK, De Los Reyes T, Nian C, Asadi A, Seino Y, Kieffer TJ, Kwok YN, McIntish CH. A GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control. PLoS One. In press.
42. Yang GK, Chen JF, Kieffer TJ, Kwok YN. Regulation of somatostatin release by adenosine in the mouse stomach. J Pharmacol Exp Ther 329: 729-737, 2009.
43. Yeung CM, Mojsov S, Mok PY, Chow BK. Isolation and structure-function studies of a glucagon-like peptide 1 receptor from goldfish Carassius auratus: identification of three charged residues in extracellular domains critical for receptor function. Endocrinology 143: 4646-4654, 2002.